{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T10:07:13Z","timestamp":1695550033696},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T00:00:00Z","timestamp":1428019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00262-015-1683-7","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T12:30:13Z","timestamp":1428064213000},"page":"791-804","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Two distinct effector memory cell populations of WT1 (Wilms\u2019 tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients"],"prefix":"10.1007","volume":"64","author":[{"given":"Yoshiki","family":"Nakae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyoko","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiyuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichi","family":"Kyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Oji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,3]]},"reference":[{"issue":"7","key":"1683_CR1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0092-8674(90)90690-G","volume":"61","author":"DA Haber","year":"1990","unstructured":"Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms\u2019 tumor. Cell 61(7):1257\u20131269","journal-title":"Cell"},{"issue":"6260","key":"1683_CR2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/343774a0","volume":"343","author":"M Gessler","year":"1990","unstructured":"Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343(6260):774\u2013778","journal-title":"Nature"},{"issue":"5070","key":"1683_CR3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1323141","volume":"257","author":"IA Drummond","year":"1992","unstructured":"Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ 3rd (1992) Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257(5070):674\u2013678","journal-title":"Science"},{"issue":"22","key":"1683_CR4","first-page":"5386","volume":"55","author":"SM Hewitt","year":"1995","unstructured":"Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ 3rd, Saunders GF (1995) Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms\u2019 tumor suppressor gene WT1. Cancer Res 55(22):5386\u20135389","journal-title":"Cancer Res"},{"issue":"3","key":"1683_CR5","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1128\/MCB.19.3.2289","volume":"19","author":"J Kim","year":"1999","unstructured":"Kim J, Prawitt D, Bardeesy N, Torban E, Vicaner C, Goodyer P, Zabel B, Pelletier J (1999) The Wilms\u2019 tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation. Mol Cell Biol 19(3):2289\u20132299","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1683_CR6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/jjco\/hyp194","volume":"40","author":"H Sugiyama","year":"2010","unstructured":"Sugiyama H (2010) WT1 (Wilms\u2019 tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol 40(5):377\u2013387","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"1683_CR7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/modpathol.3800588","volume":"19","author":"S Nakatsuka","year":"2006","unstructured":"Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, Kawano K, Kuwae Y, Yamauchi A, Okumura M, Kitamura Y, Oka Y, Kawase I, Sugiyama H, Aozasa K (2006) Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 19(6):804\u2013814","journal-title":"Mod Pathol"},{"issue":"2","key":"1683_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.coi.2008.04.009","volume":"20","author":"Y Oka","year":"2008","unstructured":"Oka Y, Tsuboi A, Oji Y, Kawase I, Sugiyama H (2008) WT1 peptide vaccine for the treatment of cancer. Curr Opin Immunol 20(2):211\u2013220","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"1683_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02981935","volume":"73","author":"H Sugiyama","year":"2001","unstructured":"Sugiyama H (2001) Wilms\u2019 tumor gene WT1: its oncogenic function and clinical application. Int J Hematol 73(2):177\u2013187","journal-title":"Int J Hematol"},{"issue":"17","key":"1683_CR10","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","volume":"15","author":"MA Cheever","year":"2009","unstructured":"Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM (2009) The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 15(17):5323\u20135337","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1683_CR11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1634\/theoncologist.2011-0240","volume":"17","author":"A Driessche Van","year":"2012","unstructured":"Van Driessche A, Berneman ZN, Van Tendeloo VF (2012) Active specific immunotherapy targeting the Wilms\u2019 tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials. Oncologist 17(2):250\u2013259","journal-title":"Oncologist"},{"issue":"2","key":"1683_CR12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood-2009-10-250993","volume":"116","author":"PG Maslak","year":"2010","unstructured":"Maslak PG, Dao T, Krug LM, Chanel S, Korontsvit T, Zakhaleva V, Zhang R, Wolchok JD, Yuan J, Pinilla-Ibarz J, Berman E, Weiss M, Jurcic J, Frattini MG, Scheinberg DA (2010) Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia. Blood 116(2):171\u2013179","journal-title":"Blood"},{"issue":"4","key":"1683_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jjco\/hyl005","volume":"3\u20136","author":"S Morita","year":"2006","unstructured":"Morita S, Oka Y, Tsuboi A, Kawakami M, Maruno M, Izumoto S, Osaki T, Taguchi T, Ueda T, Myoui A, Nishida S, Shirakata T, Ohno S, Oji Y, Aozasa K, Hatazawa J, Udaka K, Yoshikawa H, Yoshimine T, Noguchi S, Kawase I, Nakatsuka S, Sugiyama H, Sakamoto J (2006) A phase I\/II trial of a WT1 (Wilms\u2019 tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data. Jpn J Clin Oncol 3\u20136(4):231\u2013236","journal-title":"Jpn J Clin Oncol"},{"issue":"31","key":"1683_CR14","doi-asserted-by":"crossref","first-page":"13824","DOI":"10.1073\/pnas.1008051107","volume":"107","author":"VF Tendeloo Van","year":"2010","unstructured":"Van Tendeloo VF, Van de Velde A, Van Driessche A, Cools N, Anguille S, Ladell K, Gostick E, Vermeulen K, Pieters K, Nijs G, Stein B, Smits EL, Schroyens WA, Gadisseur AP, Vrelust I, Jorens PG, Goossens H, de Vries IJ, Price DA, Oji Y, Oka Y, Sugiyama H, Berneman ZN (2010) Induction of complete and molecular remissions in acute myeloid leukemia by Wilms\u2019 tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci USA 107(31):13824\u201313829","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1683_CR15","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/leu.2011.343","volume":"26","author":"A Tsuboi","year":"2012","unstructured":"Tsuboi A, Oka Y, Kyo T, Katayama Y, Elisseeva OA, Kawakami M, Nishida S, Morimoto S, Murao A, Nakajima H, Hosen N, Oji Y, Sugiyama H (2012) Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease. Leukemia 26(6):1410\u20131413","journal-title":"Leukemia"},{"issue":"3","key":"1683_CR16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/leu.2011.226","volume":"26","author":"Y Hashii","year":"2012","unstructured":"Hashii Y, Sato-Miyashita E, Matsumura R, Kusuki S, Yoshida H, Ohta H, Hosen N, Tsuboi A, Oji Y, Oka Y, Sugiyama H, Ozono K (2012) WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission. Leukemia 26(3):530\u2013532","journal-title":"Leukemia"},{"issue":"38","key":"1683_CR17","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1073\/pnas.0405884101","volume":"101","author":"Y Oka","year":"2004","unstructured":"Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H, Elisseeva OA, Oji Y, Kawakami M, Ikegame K, Hosen N, Yoshihara S, Wu F, Fujiki F, Murakami M, Masuda T, Nishida S, Shirakata T, Nakatsuka S, Sasaki A, Udaka K, Dohy H, Aozasa K, Noguchi S, Kawase I, Sugiyama H (2004) Induction of WT1 (Wilms\u2019 tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 101(38):13885\u201313890","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1683_CR18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0609.2010.01497.x","volume":"85","author":"Y Oji","year":"2010","unstructured":"Oji Y, Oka Y, Nishida S, Tsuboi A, Kawakami M, Shirakata T, Takahashi K, Murao A, Nakajima H, Narita M, Takahashi M, Morita S, Sakamoto J, Tanaka T, Kawase I, Hosen N, Sugiyama H (2010) WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient. Eur J Haematol 85(4):358\u2013360","journal-title":"Eur J Haematol"},{"issue":"2","key":"1683_CR19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.7150\/ijms.7.72","volume":"7","author":"M Narita","year":"2010","unstructured":"Narita M, Masuko M, Kurasaki T, Kitajima T, Takenouchi S, Saitoh A, Watanabe N, Furukawa T, Toba K, Fuse I, Aizawa Y, Kawakami M, Oka Y, Sugiyama H, Takahashi M (2010) WT1 peptide vaccination in combination with imatinib therapy for a patient with CML in the chronic phase. Int J Med Sci 7(2):72\u201381","journal-title":"Int J Med Sci"},{"issue":"5","key":"1683_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1532\/IJH97.06194","volume":"85","author":"M Kawakami","year":"2007","unstructured":"Kawakami M, Oka Y, Tsuboi A, Harada Y, Elisseeva OA, Furukawa Y, Tsukaguchi M, Shirakata T, Nishida S, Nakajima H, Morita S, Sakamoto J, Kawase I, Oji Y, Sugiyama H (2007) Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5\u00a0microg\/body) in a patient with chronic myelomonocytic leukemia. Int J Hematol 85(5):426\u2013429","journal-title":"Int J Hematol"},{"issue":"1","key":"1683_CR21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02983241","volume":"78","author":"Y Oka","year":"2003","unstructured":"Oka Y, Tsuboi A, Murakami M, Hirai M, Tominaga N, Nakajima H, Elisseeva OA, Masuda T, Nakano A, Kawakami M, Oji Y, Ikegame K, Hosen N, Udaka K, Yasukawa M, Ogawa H, Kawase I, Sugiyama H (2003) Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. Int J Hematol 78(1):56\u201361","journal-title":"Int J Hematol"},{"issue":"5","key":"1683_CR22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF02983998","volume":"86","author":"A Tsuboi","year":"2007","unstructured":"Tsuboi A, Oka Y, Nakajima H, Fukuda Y, Elisseeva OA, Yoshihara S, Hosen N, Ogata A, Kito K, Fujiki F, Nishida S, Shirakata T, Ohno S, Yasukawa M, Oji Y, Kawakami M, Morita S, Sakamoto J, Udaka K, Kawase I, Sugiyama H (2007) Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma. Int J Hematol 86(5):414\u2013417","journal-title":"Int J Hematol"},{"issue":"1","key":"1683_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10014-010-0265-9","volume":"27","author":"Y Chiba","year":"2010","unstructured":"Chiba Y, Hashimoto N, Tsuboi A, Rabo C, Oka Y, Kinoshita M, Kagawa N, Oji Y, Sugiyama H, Yoshimine T (2010) Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients. Brain Tumor Pathol 27(1):29\u201334","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"1683_CR24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jjco\/hyp196","volume":"40","author":"Y Chiba","year":"2010","unstructured":"Chiba Y, Hashimoto N, Tsuboi A, Oka Y, Murao A, Kinoshita M, Kagawa N, Oji Y, Hosen N, Nishida S, Sugiyama H, Yoshimine T (2010) Effects of concomitant temozolomide and radiation therapies on WT1-specific T-cells in malignant glioma. Jpn J Clin Oncol 40(5):395\u2013403","journal-title":"Jpn J Clin Oncol"},{"issue":"7","key":"1683_CR25","first-page":"805","volume":"61","author":"N Hashimoto","year":"2009","unstructured":"Hashimoto N, Tsuboi A, Chiba Y, Izumoto S, Oka Y, Yoshimine T, Sugiyama H (2009) Immunotherapy targeting the Wilms\u2019 tumor 1 gene product for patients with malignant brain tumors. Brain Nerve 61(7):805\u2013814","journal-title":"Brain Nerve"},{"issue":"5","key":"1683_CR26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3171\/JNS\/2008\/108\/5\/0963","volume":"108","author":"S Izumoto","year":"2008","unstructured":"Izumoto S, Tsuboi A, Oka Y, Suzuki T, Hashiba T, Kagawa N, Hashimoto N, Maruno M, Elisseeva OA, Shirakata T, Kawakami M, Oji Y, Nishida S, Ohno S, Kawase I, Hatazawa J, Nakatsuka S, Aozasa K, Morita S, Sakamoto J, Sugiyama H, Yoshimine T (2008) Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme. J Neurosurg 108(5):963\u2013971","journal-title":"J Neurosurg"},{"issue":"2","key":"1683_CR27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1684\/ejd.2011.1619","volume":"22","author":"M Nishioka","year":"2012","unstructured":"Nishioka M, Tanemura A, Nishida S, Nakano A, Tsuboi A, Oji Y, Oka Y, Azuma I, Sugiyama H, Katayama I (2012) Vaccination with WT-1 (Wilms\u2019 tumor gene-1) peptide and BCG-CWS in melanoma. Eur J Dermatol 22(2):258\u2013259","journal-title":"Eur J Dermatol"},{"issue":"3","key":"1683_CR28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1348-0421.2004.tb03503.x","volume":"48","author":"A Tsuboi","year":"2004","unstructured":"Tsuboi A, Oka Y, Osaki T, Kumagai T, Tachibana I, Hayashi S, Murakami M, Nakajima H, Elisseeva OA, Fei W, Masuda T, Yasukawa M, Oji Y, Kawakami M, Hosen N, Ikegame K, Yoshihara S, Udaka K, Nakatsuka S, Aozasa K, Kawase I, Sugiyama H (2004) WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases. Microbiol Immunol 48(3):175\u2013184","journal-title":"Microbiol Immunol"},{"issue":"2","key":"1683_CR29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/CJI.0000000000000020","volume":"37","author":"S Nishida","year":"2014","unstructured":"Nishida S, Koido S, Takeda Y, Homma S, Komita H, Takahara A, Morita S, Ito T, Morimoto S, Hara K, Tsuboi A, Oka Y, Yanagisawa S, Toyama Y, Ikegami M, Kitagawa T, Eguchi H, Wada H, Nagano H, Nakata J, Nakae Y, Hosen N, Oji Y, Tanaka T, Kawase I, Kumanogoh A, Sakamoto J, Doki Y, Mori M, Ohkusa T, Tajiri H, Sugiyama H (2014) Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer. J Immunother 37(2):105\u2013114","journal-title":"J Immunother"},{"issue":"9","key":"1683_CR30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00262-011-1033-3","volume":"60","author":"A Takahara","year":"2011","unstructured":"Takahara A, Koido S, Ito M, Nagasaki E, Sagawa Y, Iwamoto T, Komita H, Ochi T, Fujiwara H, Yasukawa M, Mineno J, Shiku H, Nishida S, Sugiyama H, Tajiri H, Homma S (2011) Gemcitabine enhances Wilms\u2019 tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. Cancer Immunol Immnother 60(9):1289\u20131297","journal-title":"Cancer Immunol Immnother"},{"issue":"3","key":"1683_CR31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00432-012-1348-2","volume":"139","author":"T Miyatake","year":"2013","unstructured":"Miyatake T, Ueda Y, Morimoto A, Enomoto T, Nishida S, Shirakata T, Oka Y, Tsuboi A, Oji Y, Hosen N, Nakatsuka S, Morita S, Sakamoto J, Sugiyama H, Kimura T (2013) WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial. J Cancer Res Colin Oncol 139(3):457\u2013463","journal-title":"J Cancer Res Colin Oncol"},{"issue":"7","key":"1683_CR32","first-page":"2441","volume":"31","author":"S Dohi","year":"2011","unstructured":"Dohi S, Ohno S, Ohno Y, Takakura M, Kyo S, Soma G, Sugiyama H, Inoue M (2011) WT1 peptide vaccine stabilized intractable ovarian cancer patient for one year: a case report. Anticancer Res 31(7):2441\u20132445","journal-title":"Anticancer Res"},{"issue":"11","key":"1683_CR33","first-page":"4779","volume":"29","author":"S Ohno","year":"2009","unstructured":"Ohno S, Kyo S, Myojo S, Dohi S, Ishizaki J, Miyamoto K, Morita S, Sakamoto J, Enomoto T, Kimura T, Oka Y, Tsuboi A, Sugiyama H, Inoue M (2009) Wilms\u2019 tumor 1 (WT1) peptide immunotherapy for gynecological malignancy. Anticancer Res 29(11):4779\u20134784","journal-title":"Anticancer Res"},{"issue":"5","key":"1683_CR34","first-page":"1691","volume":"29","author":"S Ohno","year":"2009","unstructured":"Ohno S, Dohi S, Ohno Y, Kyo S, Sugiyama H, Suzuki N, Inoue M (2009) Immunohistochemical detection of WT1 protein in endometrial cancer. Anticancer Res 29(5):1691\u20131695","journal-title":"Anticancer Res"},{"issue":"1","key":"1683_CR35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.oraloncology.2010.10.007","volume":"47","author":"E Sasabe","year":"2011","unstructured":"Sasabe E, Hamada F, Iiyama T, Udaka K, Sugiyama H, Yamamoto T (2011) Wilm\u2019s tumor gene WT1 peptide immunotherapy for pulmonary metastasis from adenoid cystic carcinoma of the salivary gland. Oral Oncol 47(1):77\u201378","journal-title":"Oral Oncol"},{"issue":"3","key":"1683_CR36","first-page":"1081","volume":"32","author":"T Shirakata","year":"2012","unstructured":"Shirakata T, Oka Y, Nishida S, Hosen N, Tsuboi A, Oji Y, Murao A, Tanaka H, Nakatsuka S, Inohara H, Sugiyama H (2012) WT1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer. Anticancer Res 32(3):1081\u20131085","journal-title":"Anticancer Res"},{"issue":"2","key":"1683_CR37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/pbc.22522","volume":"55","author":"Y Hashii","year":"2010","unstructured":"Hashii Y, Sato E, Ohta H, Oka Y, Sugiyama H, Ozono K (2010) WT1 peptide immunotherapy for cancer in children and young adults. Pediatr Blood Cancer 55(2):352\u2013355","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1683_CR38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/08880010802435500","volume":"26","author":"H Ohta","year":"2009","unstructured":"Ohta H, Hashii Y, Yoneda A, Takizawa S, Kusuki S, Tokimasa S, Fukuzawa M, Tsuboi A, Murao A, Oka Y, Oji Y, Aozasa K, Nakatsuka S, Sugiyama H, Ozono K (2009) WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report. Pediatr Hematol Oncol 26(1):74\u201383","journal-title":"Pediatr Hematol Oncol"},{"issue":"4","key":"1683_CR39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymeth.2010.01.002","volume":"50","author":"A Stahlberg","year":"2010","unstructured":"Stahlberg A, Bengtsson M (2010) Single-cell gene expression profiling using reverse transcription quantitative real-time PCR. Methods 50(4):282\u2013288","journal-title":"Methods"},{"issue":"5","key":"1683_CR40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nprot.2012.021","volume":"7","author":"V Sanchez-Freire","year":"2012","unstructured":"Sanchez-Freire V, Ebert AD, Kalisky T, Quake SR, Wu JC (2012) Microfluidic single-cell real-time PCR for comparative analysis of gene expression patterns. Nat Protoc 7(5):829\u2013838","journal-title":"Nat Protoc"},{"key":"1683_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fimmu.2013.00031","volume":"4","author":"VR Buchholz","year":"2013","unstructured":"Buchholz VR, Graf P, Busch DH (2013) Review: The smallest unit: effector and memory CD8(+) T cell differentiation on the single-cell level. Front Immunol 4:31","journal-title":"Front Immunol"},{"issue":"1","key":"1683_CR42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4049\/jimmunol.167.1.212","volume":"167","author":"JM Faint","year":"2001","unstructured":"Faint JM, Annels NE, Curnow SJ, Shields P, Pilling D, Hislop AD, Wu L, Akbar AN, Buckley CD, Moss PA, Adams DH, Rickinson AB, Salmon M (2001) Memory T cells constitute a subset of the human CD8+ CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol 167(1):212\u2013220","journal-title":"J Immunol"},{"issue":"11","key":"1683_CR43","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.4049\/jimmunol.168.11.5538","volume":"168","author":"H Tomiyama","year":"2002","unstructured":"Tomiyama H, Matsuda T, Takiguchi M (2002) Differentiation of human CD8(+) T cells from a memory to memory\/effector phenotype. J Immunol 168(11):5538\u20135550","journal-title":"J Immunol"},{"issue":"6","key":"1683_CR44","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.celrep.2013.04.034","volume":"3","author":"SM Morgani","year":"2013","unstructured":"Morgani SM, Canham MA, Nichols J, Sharov AA, Migueles RP, Ko MS, Brickman JM (2013) Totipotent embryonic stem cells arise in ground-state culture conditions. Cell Rep 3(6):1945\u20131957","journal-title":"Cell Rep"},{"issue":"1","key":"1683_CR45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ymeth.2012.10.004","volume":"59","author":"KJ Livak","year":"2013","unstructured":"Livak KJ, Wills QF, Tipping AJ, Datta K, Mittal R, Goldson AJ, Sexton DW, Holmes CC (2013) Methods for qPCR gene expression profiling applied to 1440 lymphoblastoid single-cells. Methods 59(1):71\u201379","journal-title":"Methods"},{"issue":"1","key":"1683_CR46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nprot.2011.430","volume":"7","author":"A Citri","year":"2011","unstructured":"Citri A, Pang ZP, Sudhof TC, Wernig M, Malenka RC (2011) Comprehensive qPCR profiling of gene expression in single neuronal cells. Nat Protoc 7(1):118\u2013127","journal-title":"Nat Protoc"},{"issue":"4","key":"1683_CR47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri3173","volume":"12","author":"NP Weng","year":"2012","unstructured":"Weng NP, Araki Y, Subedi K (2012) The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat Rev Immunol 12(4):306\u2013315","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1683_CR48","doi-asserted-by":"crossref","first-page":"e17844","DOI":"10.1371\/journal.pone.0017844","volume":"6","author":"YA Chen","year":"2011","unstructured":"Chen YA, Tripathi LP, Mizuguchi K (2011) TargetMine, an integrated data warehouse for candidate gene prioritisation and target discovery. PLoS One 6(3):e17844","journal-title":"PLoS One"},{"issue":"10","key":"1683_CR49","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ni.2687","volume":"14","author":"PM Gubser","year":"2013","unstructured":"Gubser PM, Bantug GR, Razik L, Fischer M, Dimeloe S, Hoenger G, Durovic B, Jauch A, Hess C (2013) Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat Immunol 14(10):1064\u20131072","journal-title":"Nat Immunol"},{"issue":"10","key":"1683_CR50","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni.2386","volume":"13","author":"R Wang","year":"2012","unstructured":"Wang R, Green DR (2012) Metabolic checkpoints in activated T cells. Nat Immunol 13(10):907\u2013915","journal-title":"Nat Immunol"},{"issue":"8","key":"1683_CR51","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/eji.201344248","volume":"44","author":"R Watanabe","year":"2014","unstructured":"Watanabe R, Fujii H, Shirai T, Saito S, Ishii T, Harigae H (2014) Autophagy plays a protective role as an anti-oxidant system in human T cells and represents a novel strategy for induction of T-cell apoptosis. Eur J Immunol 44(8):2508\u20132520","journal-title":"Eur J Immunol"},{"issue":"41","key":"1683_CR52","doi-asserted-by":"crossref","first-page":"34683","DOI":"10.1074\/jbc.M112.377143","volume":"287","author":"T Ren","year":"2012","unstructured":"Ren T, Dong W, Takahashi Y, Xiang D, Yuan Y, Liu X, Loughran TP Jr, Sun SC, Wang HG, Cheng H (2012) HTLV-2 tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy. J Biol Chem 287(41):34683\u201334693","journal-title":"J Biol Chem"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-015-1683-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1683-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T11:35:50Z","timestamp":1598873750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-015-1683-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,3]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1683-7","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,3]]}}}